Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.38 |
| ▸ | EGFR | P00533 | 1/20 | 0.38 |
| ▸ | FYN | P06241 | 1/20 | 0.38 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
| ▸ | MMP9 | P14780 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | MMP8 | P22894 | 1/20 | 0.38 |
| ▸ | CA6 | P23280 | 1/20 | 0.38 |
| ▸ | CDK2 | P24941 | 1/20 | 0.38 |
| ▸ | MMP12 | P39900 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.38 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7905207 | 0.78 | HNF4A (0.48) | ALDH1A1HSD17B10HPGD | |
| SCHEMBL7187789 | 0.74 | — | — | |
| SCHEMBL8020131 | 0.74 | ALOX15 (0.38) | CA2ALDH1A1LMNAHSD17B10CA1 | |
| SCHEMBL1970573 | 0.74 | APOBEC3G (0.38) | LMNAHSD17B10HPGDAPOBEC3GTSHR | |
| SCHEMBL5378587 | 0.73 | — | — | |
| SCHEMBL28338819 | 0.72 | ALDH1A1 (0.36) | CA2ALDH1A1LMNAHSD17B10CA1 | |
| Hydrogen Sulfide SCHEMBL10815992 | 0.72 | ALDH1A1 (0.45) | CA2ALDH1A1LMNAHSD17B10CA1 | |
| SCHEMBL199801 | 0.71 | GABRA1 (0.42) | CA2ALDH1A1LMNAHSD17B10CA1 | |
| SCHEMBL9633956 | 0.69 | APOBEC3G (0.67) | LMNAHPGDAPOBEC3GTSHRSLC6A2 | |
| SCHEMBL711355 | 0.68 | CYP2C9 (0.56) | HPGDMMP2MMP9MMP12TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104817801-B | Inorganic-organic Hybrid Material and the optical material and inorganic-organic composite composition for having used the Inorganic-organic Hybrid Material | 日本化成株式会社 | 2017-07-18 | — | — | CN | disclosed |
| CN-104208848-B | golf ball | 邓禄普体育用品株式会社 | 2017-04-12 | — | — | CN | disclosed |
| US-7279484-B2 | Suppress tumor necrosis factor; Crohn's disease; imflammatory bowel disorders; sepsis; autoimmune disease | AJINOMOTO CO., INC. (JP) | 2007-10-09 | — | — | US | disclosed |
| US-20050250796-A1 | Suppress tumor necrosis factor; Crohn's disease; imflammatory bowel disorders; sepsis; autoimmune disease | AJINOMOTO CO., INC. (JP) | 2005-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050250796-A1 | Suppress tumor necrosis factor; Crohn's disease; imflammatory bowel disorders; sepsis; autoimmune disease | TNF, NOD2, LITAF | CA2 3056/4885ALDH1A1 3789/4885LMNA 1848/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.